Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/1998
03/26/1998WO1998012311A2 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
03/26/1998WO1998012306A1 Hematopoietic stem cells and methods for generating such cells
03/26/1998WO1998012304A1 Culture system for hematopoietic stem cells
03/26/1998WO1998012226A1 Methods of ameliorating cancer and of inhibiting angiogenesis by using fibronectin
03/26/1998WO1998012220A2 Novel tumor proteins
03/26/1998WO1998012204A1 Human b-cell translocation genes-2 and 3
03/26/1998WO1998011828A1 Stent lining
03/26/1998WO1998011779A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998WO1998007874A3 New systems for regulating genetic expression
03/26/1998WO1998003653A3 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor
03/26/1998WO1998001159A3 Composition for enhanced uptake of polar drugs from mucosal surfaces
03/26/1998WO1997049832A3 Method of identifying cytochrome p450
03/26/1998WO1997048815A3 Method for enhancing gene transfer
03/26/1998WO1997048724A3 Human metabotropic glutamate receptor
03/26/1998WO1997046672A3 Antisense nucleic acids and hammerhead ribozymes
03/26/1998WO1997040072A3 Adam proteins and uses thereof
03/26/1998WO1997036535A3 Biomarkers for detection, diagnosis and prognosis of prostate cancer
03/26/1998WO1997035990A3 Histone deacetylases, and uses related thereto
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998DE19639103A1 DNA construct with inhibitory mutation and corrective mutation
03/26/1998CA2267288A1 Hematopoietic stem cells and methods for generating such cells
03/26/1998CA2266656A1 Compositions and methods for treating intracellular diseases
03/26/1998CA2266425A1 Human b-cell translocation genes-2 and 3
03/26/1998CA2264744A1 Delivery of therapeutic gene products by intestinal cell expression
03/26/1998CA2263818A1 Novel tumor proteins
03/25/1998EP0831148A1 Human adhesion molecule occludin
03/25/1998EP0830604A1 Methods and uses for apoptin
03/25/1998EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
03/25/1998EP0830452A1 Immune-evading proteins
03/25/1998EP0830450A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
03/25/1998EP0830375A1 Human inhibitor of apoptosis gene 1
03/25/1998EP0830140A1 A pluripotent vaccine against enveloped viruses
03/25/1998CN1177378A Stabilized external guide sequences
03/25/1998CN1177342A Novel cationic lipids and the use thereof
03/25/1998CN1177291A Stable lipid-comprising drug delivery complexes and method for producing same
03/24/1998US5731294 Inhibition of neovasularization using VEGF-specific oligonucleotides
03/24/1998US5731190 Penton base protein and methods of using same
03/24/1998US5731182 Non-mammalian DNA virus to express an exogenous gene in a mammalian cell
03/24/1998US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof
03/24/1998CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy
03/19/1998WO1998011254A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA (α), HNF-1β AND HNF-4$g(a)
03/19/1998WO1998011245A1 Sustained delivery device and methods of making and using the same
03/19/1998WO1998011244A2 Aav4 vector and uses thereof
03/19/1998WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011233A1 Novel human phosphorylase kinase gamma subunit
03/19/1998WO1998011229A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same
03/19/1998WO1998011224A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
03/19/1998WO1998011213A1 Method for treating amyotrophic lateral sclerosis
03/19/1998WO1998011212A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998WO1998011208A1 Method for preparing a plasmid dna
03/19/1998WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
03/19/1998WO1998011204A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998WO1998011136A1 A cDNA AND PEPTIDE WITH RELATION TO CANCER AND WEIGHT LOSS
03/19/1998WO1998011123A1 Carbamate-derivatized nucleosides and oligonucleosides
03/19/1998WO1998011082A1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
03/19/1998WO1998010796A1 Compositions and methods for pulmonary gene delivery
03/19/1998WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
03/19/1998WO1998010778A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1β-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS
03/19/1998WO1998010750A2 Nucleic acid particle delivery
03/19/1998WO1998010748A1 Liposomes
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998WO1998000541A3 Methods for administration of recombinant gene delivery vehicles for treatment of human disease
03/19/1998DE19637043A1 Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel und Reagenzien New amino alcohol derivatives, processes for their preparation and pharmaceutical compositions containing them and reagents
03/19/1998CA2698393A1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) 1 alpha (.alpha.), hnf-1.beta. and hnf-4.alpha.
03/19/1998CA2266123A1 Method for preparing a plasmid dna
03/19/1998CA2265933A1 Sustained delivery device and methods of making and using the same
03/19/1998CA2265913A1 Methods and reagents for regulating telomere length and telomerase activity
03/19/1998CA2265887A1 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998CA2265838A1 Compositions and methods for pulmonary gene delivery
03/19/1998CA2265765A1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2265460A1 Aav4 vector and uses thereof
03/19/1998CA2264966A1 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998CA2264545A1 Novel human phosphorylase kinase gamma subunit
03/19/1998CA2264541A1 Human protein kinases
03/19/1998CA2259283A1 Method for treating amyotrophic lateral sclerosis
03/18/1998EP0828839A1 Animal gene therapy
03/18/1998EP0828832A2 $g(D)P62, ITS VARIANTS, NUCLEIC ACID SEQUENCES ENCODING THEM, AND THEIR USES IN ANTI-CANCER GENE THERAPY
03/18/1998EP0828831A2 A novel human purinergic p 2u? receptor
03/18/1998EP0828519A1 Recombinant viral vector system
03/18/1998EP0828518A1 Gene transfer for treating a connective tissue of a mammalian host
03/18/1998EP0828510A1 Abundant extracellular products and methods for their production and use
03/18/1998CN1176662A Identification of genes
03/17/1998US5728868 Prodrugs of protein tyrosine kinase inhibitors
03/17/1998US5728819 Secreted proteins and polynucleotides encoding them
03/17/1998US5728523 Polymerase delta mutations in colorectal tumors with replication errors
03/17/1998US5728521 Targeted cleavage of RNA using eukaryotic ribonuclease P and external guide sequence
03/17/1998US5728518 Soluble complex of a poly- or oligonucleotide and a carrier
03/17/1998US5728387 Structural gene of pneumococcal protein
03/17/1998US5728379 Tumor- or cell-specific herpes simplex virus replication
03/12/1998WO1998010090A1 Gata-6 transcription factor: compositions and methods
03/12/1998WO1998010087A1 Chimpanzee adenovirus vectors
03/12/1998WO1998010086A1 Methods using cre-lox for production of recombinant adeno-associated viruses
03/12/1998WO1998010085A2 Gene therapy for congestive heart failure
03/12/1998WO1998010083A1 Herpesvirus saimiri as viral vector
03/12/1998WO1998010071A1 Angiogenic factor and use thereof in treating cardiovascular disease
03/12/1998WO1998010058A1 Human cns cell lines and methods of use therefor
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist